EZH2 and neoplasm: However, other studies have pointed out that long-term incubation (>120 h) with tazemetostat is required since EZH2 inhibition, as an epigenetic intervention, has a certain latency before the manifestation of a reduction in cell viability by the delayed activation of specific tumor suppressor genes which are downstream targets of EZH2 [32,33].